Mitsuhiro Ibe
President at ZERIA PHARMACEUTICAL CO., LTD.
Net worth: 1 M $ as of 2024-03-30
Profile
Mitsuhiro Ibe currently works at Tillotts Pharma AG, as Non Executive Director and Zeria Pharmaceutical Co., Ltd., as President, COO & Representative Director from 2014.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-03-30 | 77,000 ( 0.14% ) | 1 M $ | 2024-03-30 |
Mitsuhiro Ibe active positions
| Companies | Position | Start |
|---|---|---|
| ZERIA PHARMACEUTICAL CO., LTD. | President | 2014-05-31 |
Tillotts Pharma AG
 Tillotts Pharma AG Pharmaceuticals: MajorHealth Technology Tillotts Pharma AG manufactures pharmaceuticals for treatment of gastrointestinal diseases. The firm specializes in the therapy of the lower gastrointestinal tract. It offers Asacol, Entocort, Colpermin, Tillhepo and VistaPrep. The company was founded in 1986 and is headquartered in Ziefen, Switzerland. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ZERIA PHARMACEUTICAL CO., LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Tillotts Pharma AG
Tillotts Pharma AG Pharmaceuticals: MajorHealth Technology Tillotts Pharma AG manufactures pharmaceuticals for treatment of gastrointestinal diseases. The firm specializes in the therapy of the lower gastrointestinal tract. It offers Asacol, Entocort, Colpermin, Tillhepo and VistaPrep. The company was founded in 1986 and is headquartered in Ziefen, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Mitsuhiro Ibe
